Lung Cancer Clinical Trial

Piloting ‘mPal,’ a Multilevel Strategy for Palliative Care Implementation

Summary

The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.

View Full Description

Full Description

In this study, 60 advanced stage lung cancer patients will be randomized to mPal's patient-level component or usual care. Oncology providers will receive the mPal intervention. mPal is designed to help oncology providers integrate outpatient palliative care (non-hospice palliative care; NHPC) into routine clinical practice through: 1) electronic health record enhancements; 2) patient education and preparation for NHPC discussions when patients are in clinic to see their oncology providers; and 3) provider education about NHPC.

This study will examine the feasibility and acceptability of mPal and gather preliminary data on potential outcomes for a future effectiveness trial.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

new or recurrent AJCC stage IIIb-IV non-small cell lung cancer or extensive stage small cell lung cancer
ECOG performance status 0-3/Karnofsky 40-100
at least three weeks into active oncologic treatment (chemotherapy, immunotherapy, chemo-immunotherapy)

Exclusion Criteria:

unstable brain metastases
Cognitive (i.e., dementia) or psychiatric condition (e.g., psychotic disorder) for which participating would be inappropriate
Receiving palliative care
Unable to speak and read English

Study is for people with:

Lung Cancer

Estimated Enrollment:

60

Study ID:

NCT05270395

Recruitment Status:

Recruiting

Sponsor:

Laurie McLouth

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Kentucky
Lexington Kentucky, 40506, United States More Info
Laurie McLouth, PhD
Contact
859-562-2526
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

60

Study ID:

NCT05270395

Recruitment Status:

Recruiting

Sponsor:


Laurie McLouth

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider